Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis Pharma AG
Woman and Man Max 99 years
Novartis Pharma AG
Update Il y a 4 ans
A randomized, double blind, placebo controlled, multicenter study to determine the effect of QVA149 on mean 24-hours heart rate in patients with Chronic Obstructive Pulmonary Disease (COPD)
To assess the effect of 14 days treatment with QVA149 600µg/100µg, QVA149 300µg/100µg, QVA149 150µg/100µg on change in mean 24-h heart rate (ventricular rate) compared to placebo delivered by the Sing...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma AG
Update Il y a 4 ans
A multicenter, randomized, double-blind, placebocontrolled study, to assess the long term safety of 52 weeks treatment with QVA149 (110μg indacaterol / 50μg glycopyrrolate) in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)
To assess the safety/tolerability of 52 weeks of treatment with QVA149 (110μg indacaterol/50μg glycopyrrolate) once a day on adverse event reporting rate in patients with moderate or severe Chronic Ob...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
2
3
4
5
6
7